Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions

A number of pharmacokinetic and pharmacodynamic factors in critically ill or severely immunosuppressed patients influence the effectiveness of antifungal therapy making dosing less certain. Recent position papers from infectious diseases societies and working groups have proposed methods for dosage...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Russell E., Andes, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
INFECTIONS OF THE IMMUNOCOMPROMISED HOST: Edited by Genovefa A. Papanicolaou and Dionysios Neofytos
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914162/
https://www.ncbi.nlm.nih.gov/pubmed/34010233
http://dx.doi.org/10.1097/QCO.0000000000000740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914162/
https://www.ncbi.nlm.nih.gov/pubmed/34010233
http://dx.doi.org/10.1097/QCO.0000000000000740

Ejemplares similares